Executive Insights Realscreen Live you will have the opportunity to gain valuable intel and perspective from leading industry execs via Executive Insights. Executive Insights is designed to give delegates access to executives in . June 1, 2021
Realscreen Live you will have the opportunity to gain valuable intel and perspective from leading industry execs via
Executive Insights. Executive Insights is designed to give delegates access to executives in unscripted and non-fiction entertainment who will provide valuable knowledge about aspects of the business and give you the opportunity to ask questions that will help guide you in your career. Seating at each table is limited to 7 delegates and is available on a first-come, first-served basis.
This special Deep Tech Deep Dive report is free to download and includes expert commentary from industry, academia, and venture capitalists. (Graphic: Business Wire)
The report defines deep tech as an interdisciplinary approach to solving fundamental issues â one that leverages several advanced technologies to reimagine what is possible.
Deep Tech Deep Dive provides an overview of early-stage research at the University of Chicago in addition to highlighting success stories of discoveries and technologies that are now on the market. TO DOWNLOAD THIS FREE REPORT, CLICK HERE.
Experts including Energy Foundryâs CEO Jason Blumberg and Boston Consulting Group managing director and partner Ania Labno examine the ecosystem needed to support deep tech innovation, outline growth and investment, as well as the challenges to tackling some of societyâs biggest global challenges.
The 12 biggest health care stories of the year. (Theyâre not all about Covid-19.)
⋮
The new coronavirus dominated news headlines this year. But what were the biggest health care stories of the year? Advisory Board experts round up their top picks for the year including three that are not related to Covid-19. Vice President, Life Sciences and Ecosystem Research
It s hard to think of a bigger story of 2020 than the coronavirus vaccine. With the entire world watching, pharmaceutical companies revolutionized the vaccine development process, and less than a year later we have not one but two authorized vaccine s that demonstrated well over 90% efficacy in Phase III trials. This can only be described as a remarkable scientific achievement.